A p16 pathway to prevention: Senescence as a driver of tau-mediated neurodegeneration
- PMID: 40706558
- DOI: 10.1016/j.neuron.2025.06.024
A p16 pathway to prevention: Senescence as a driver of tau-mediated neurodegeneration
Abstract
In this issue of Neuron, Graves et al.1 report that genetically reducing senescent cells by deleting p16 in a tauopathy mouse model significantly lessens tau pathology, neurovascular dysfunction, and behavioral deficits. Their study highlights the crucial role of p16-dependent senescence in microglia and endothelial cells as active drivers of neurodegeneration.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests G.B. consults for SciNeuro Pharmaceuticals.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
